Weiwei Tang

机构：Changsha Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, The First Hospital of Changsha, Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0002-8516-819X

发表论文 170 篇 · 总被引 7428 次 · h-index 41

代表论文

• Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives (2024 · Signal Transduction and Targeted Therapy · 被引 238)
• Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis (2024 · Journal of Controlled Release · 被引 46)
• GJB2 Promotes HCC Progression by Activating Glycolysis Through Cytoplasmic Translocation and Generating a Suppressive Tumor Microenvironment Based on Single Cell RNA Sequencing (2024 · Advanced Science · 被引 24)
• MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing (2024 · Cell Death and Disease · 被引 23)
• Hyaluronic acid-curcumin nanoparticles for preventing the progression of experimental autoimmune uveitis through the Keap1/Nrf2/HO-1 signaling pathway (2025 · Journal of Nanobiotechnology · 被引 17)
• Metabolomics reveals ascorbic acid inhibits ferroptosis in hepatocytes and boosts the effectiveness of anti-PD1 immunotherapy in hepatocellular carcinoma (2024 · Cancer Cell International · 被引 10)